Literature DB >> 32111626

Wolraich ML, Hagan JF, Allan C, et al; Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019;144(4):e20192528.

.   

Abstract

Entities:  

Year:  2020        PMID： 32111626     DOI： 10.1542/peds.2019-3997

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  14 in total

Review 1.  Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.

Authors:  Nada A Elsayed; Kaila M Yamamoto; Tanya E Froehlich
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

2.  Co-Occurrence of Neurodevelopmental Disorders in Pediatric Sickle Cell Disease.

Authors:  Eboni I Lance; Alicia D Cannon; Bruce K Shapiro; Li-Ching Lee; Michael V Johnston; James F Casella
Journal:  J Dev Behav Pediatr       Date:  2021-08-01       Impact factor: 2.988

3.  Do Parents' ADHD Symptoms Affect Treatment for their Children? The Impact of Parental ADHD on Adherence to Behavioral Parent Training for Childhood ADHD.

Authors:  Lauren M Friedman; Melissa R Dvorsky; Keith McBurnett; Linda J Pfiffner
Journal:  J Abnorm Child Psychol       Date:  2020-11

4.  Use of Stimulant Diversion Prevention Strategies in Pediatric Primary Care and Associations With Provider Characteristics.

Authors:  Elizabeth A McGuier; David J Kolko; Heather M Joseph; Heidi L Kipp; Rachel A Lindstrom; Sarah L Pedersen; Geetha A Subramaniam; Brooke S G Molina
Journal:  J Adolesc Health       Date:  2021-01-11       Impact factor: 5.012

5.  Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Raissa Carolina F Cândido; Cristiane A Menezes de Padua; Su Golder; Daniela R Junqueira
Journal:  Cochrane Database Syst Rev       Date:  2021-01-18

6.  Many Young Children with Autism Who Use Psychotropic Medication Do Not Receive Behavior Therapy: A Multisite Case-Control Study.

Authors:  Lisa D Wiggins; Cy Nadler; Steven Rosenberg; Eric Moody; Nuri Reyes; Ann Reynolds; Aimee Alexander; Julie Daniels; Kathleen Thomas; Ellen Giarelli; Susan E Levy
Journal:  J Pediatr       Date:  2021-01-22       Impact factor: 6.314

7.  Height, weight, and cardiovascular effects of stimulants on children with brain tumors.

Authors:  Raja B Khan; Maha Bano; Fang Wang; Pan Haitao; Anthony Christensen; Jessica Smith; Andrea Simmons; Zsila S Sadighi
Journal:  Pediatr Blood Cancer       Date:  2020-10-13       Impact factor: 3.167

8.  A Retrospective Examination of the Impact of Pharmacotherapy on Parent-Child Interaction Therapy.

Authors:  Chris Wang; Yuliang Hu; Paul A Nakonezny; Valeria Melo; Chelsea Ale; Arjun P Athreya; Julia Shekunov; Rachel Lynch; Paul E Croarkin; Magdalena Romanowicz
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-07-28       Impact factor: 2.576

9.  Trends in Antipsychotic Medication Use in Young Privately Insured Children.

Authors:  Greta A Bushnell; Stephen Crystal; Mark Olfson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2020-10-20       Impact factor: 13.113

10.  A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Authors:  Azmi Nasser; Tesfaye Liranso; Toyin Adewole; Nicholas Fry; Joseph T Hull; Gregory D Busse; Fatima Chowdhry; Andrew J Cutler; Nandita Joshi Jones; Robert L Findling; Stefan Schwabe
Journal:  J Clin Psychopharmacol       Date:  2021 Jul-Aug 01       Impact factor: 3.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.